The journey from a promising molecule in a laboratory to a life-saving medication involves a complex series of chemical transformations. At the heart of this process lies the synthesis of Active Pharmaceutical Ingredients (APIs), which often relies on a chain of precisely manufactured intermediate compounds. Methanone,[2-(methylamino)-5-nitrophenyl]phenyl-, identified by its CAS number 4958-56-9, is a prime example of such a crucial pharmaceutical intermediate.

What is a Pharmaceutical Intermediate?
A pharmaceutical intermediate is a chemical compound that is produced during the multi-step synthesis of an API. It is not the final drug product but a necessary stepping stone, possessing specific structural features that will be further modified in subsequent reactions. The quality and availability of these intermediates directly impact the efficiency, cost, and final purity of the API. For procurement managers and R&D scientists, identifying reliable sources for these building blocks is paramount.

Methanone,[2-(methylamino)-5-nitrophenyl]phenyl- (CAS 4958-56-9) in API Synthesis
This specific compound, with the molecular formula C14H12N2O3 and a molecular weight of 256.25668, is valued for its functional groups that allow for targeted chemical modifications. The presence of a nitro group and a secondary amine, coupled with the benzophenone backbone, offers significant synthetic versatility:

  • Nitro Group Transformation: The nitro group (-NO2) can be readily reduced to an amine group (-NH2). This transformation is a common pathway to introduce amine functionalities, which are prevalent in many drug structures and can be further derivatized through acylation, alkylation, or sulfonylation.
  • Amine Group Reactivity: The existing secondary amine can participate in various reactions, serving as a nucleophile or being modified to alter the molecule's properties and interactions.
  • Benzophenone Core: The core structure can be retained or further functionalized to form complex ring systems or to influence the pharmacokinetic properties of the resulting API.

Manufacturers producing this compound typically ensure a high purity level (≥99%) to meet the stringent demands of pharmaceutical synthesis. This high purity minimizes the introduction of impurities that could complicate subsequent steps or compromise the safety and efficacy of the final drug.

Sourcing Methanone,[2-(methylamino)-5-nitrophenyl]phenyl-
For pharmaceutical companies and contract manufacturing organizations (CMOs), securing a consistent supply of high-quality CAS 4958-56-9 is essential. When looking to buy this intermediate, it is advisable to partner with experienced chemical manufacturers who can demonstrate robust quality control, adherence to GMP (Good Manufacturing Practice) principles where applicable, and reliable supply chain management. Manufacturers based in China often offer competitive pricing and large-scale production capabilities, making them attractive suppliers. Requesting detailed technical specifications, Certificates of Analysis (CoA), and inquiring about production capacity and lead times are crucial steps in the procurement process.

Conclusion
Methanone,[2-(methylamino)-5-nitrophenyl]phenyl- (CAS 4958-56-9) exemplifies the critical role that specialized chemical intermediates play in the pharmaceutical industry. Its versatile structure and the stringent purity requirements for its use highlight the importance of collaborating with trustworthy suppliers. As the demand for new and improved medications continues to grow, the reliable supply of such essential building blocks will remain fundamental to pharmaceutical innovation.